Schedule 13D ownership disclosure

Fate Therapeutics Inc

Security class unavailable · CUSIP: 31189P102

Event date: 2021-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-003451
Form type
SC 13D/A
Filer
FATE THERAPEUTICS INC
CIK
CIK 1434316
Filed
Jan 12, 2021
Reporting period
Jan 08, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub